JP2004536824A5 - - Google Patents

Download PDF

Info

Publication number
JP2004536824A5
JP2004536824A5 JP2003506430A JP2003506430A JP2004536824A5 JP 2004536824 A5 JP2004536824 A5 JP 2004536824A5 JP 2003506430 A JP2003506430 A JP 2003506430A JP 2003506430 A JP2003506430 A JP 2003506430A JP 2004536824 A5 JP2004536824 A5 JP 2004536824A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
seq
chimeric monoclonal
acid sequence
organism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003506430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536824A (ja
Filing date
Publication date
Priority claimed from US09/881,823 external-priority patent/US20020068066A1/en
Application filed filed Critical
Publication of JP2004536824A publication Critical patent/JP2004536824A/ja
Publication of JP2004536824A5 publication Critical patent/JP2004536824A5/ja
Pending legal-status Critical Current

Links

JP2003506430A 2001-06-15 2002-06-11 Ｓ．ｍｕｔａｎｓに対するヒト化モノクローナル抗体を作製するためのＤＮＡ分子および組換えＤＮＡ分子 Pending JP2004536824A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/881,823 US20020068066A1 (en) 1999-08-20 2001-06-15 Method for the treatment and prevention of dental caries
PCT/US2002/018692 WO2002102975A2 (en) 2001-06-15 2002-06-11 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans

Publications (2)

Publication Number Publication Date
JP2004536824A JP2004536824A (ja) 2004-12-09
JP2004536824A5 true JP2004536824A5 (enExample) 2005-09-22

Family

ID=25379292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003506430A Pending JP2004536824A (ja) 2001-06-15 2002-06-11 Ｓ．ｍｕｔａｎｓに対するヒト化モノクローナル抗体を作製するためのＤＮＡ分子および組換えＤＮＡ分子

Country Status (6)

Country Link
US (1) US20020068066A1 (enExample)
EP (1) EP1434799A4 (enExample)
JP (1) JP2004536824A (enExample)
AU (1) AU2002318342A2 (enExample)
CA (1) CA2448506A1 (enExample)
WO (1) WO2002102975A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569542B2 (en) 1999-08-20 2009-08-04 The Regents Of The University Of California Anti-microbial targeting chimeric pharmaceutical
US20030143234A1 (en) * 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
US7875598B2 (en) * 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
JP5775260B2 (ja) 2006-09-06 2015-09-09 シー３ ジアン インコーポレイテッド 選択的に標的化された抗菌性ペプチドおよびその使用
EP2118122B1 (en) * 2007-01-16 2015-09-23 The Regents of The University of California Novel antimicrobial peptides
AU2014203172B2 (en) * 2010-02-24 2016-03-10 Immunogen, Inc. Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
KR20230044026A (ko) 2010-02-24 2023-03-31 이뮤노젠 아이엔씨 엽산염 수용체 1 항체와 면역접합체 및 이들의 용도
CL2011003002A1 (es) * 2011-11-25 2012-05-25 Univ Pontificia Catolica Chile Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento.
WO2016049183A1 (en) * 2014-09-24 2016-03-31 Aerpio Therapeutics, Inc. Ve-ptp extracellular domain antibodies delivered by a gene therapy vector
CA3030298A1 (en) * 2016-07-20 2018-01-25 Aerpio Therapeutics, Inc. Humanized monoclonal antibodies that target ve-ptp (hptp-.beta.)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
EP0940468A1 (en) * 1991-06-14 1999-09-08 Genentech, Inc. Humanized antibody variable domain
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
EP1105425A1 (en) * 1998-08-21 2001-06-13 The Regents of the University of California Monoclonal antibodies specific for streptococcus mutans, and uses thereof
JP2004506695A (ja) * 2000-08-24 2004-03-04 ワシントン　デンタル　サービス う蝕の予防の免疫学的方法

Similar Documents

Publication Publication Date Title
RU2757813C2 (ru) Антитело против lag-3, его антигенсвязывающий фрагмент и их фармацевтическое применение
JP2022105178A (ja) 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染症を治療および予防するための組成物および方法
JP2919071B2 (ja) 癌および感染症にたいするワクチン
CN111683966B (zh) 与cd22结合的重链抗体
TWI843799B (zh) 抗pd-1抗體、其抗原結合片段及醫藥用途
TWI699376B (zh) 抗cd40抗體、其抗原結合片段及其醫藥用途
CN104640878B (zh) 交叉反应的金黄色葡萄球菌抗体
US20130267688A1 (en) Novel antibody structures derived from human germline sequences
RU2009128064A (ru) Антитела к cd44
WO2022105914A1 (zh) Cd70抗体及其应用
MY137078A (en) Recombinant antibodies associated to gangliosides. their use indiagnosis and treatment of tumors.
CN109867723B (zh) 抗人il6单克隆抗体及其制备方法和用途
JP2004536824A5 (enExample)
CN112513088A (zh) 抗ox40抗体、其抗原结合片段及其医药用途
CN114829395A (zh) 抗angptl3抗体及其应用
Lai et al. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes
JP2009524428A5 (enExample)
JP2018509147A (ja) 抗スクレロスチン抗体、その抗原結合フラグメントおよびその医薬用途
JP2003521219A5 (enExample)
KR20120016086A (ko) 슈도모나스 애루지노사 혈청형 ｉａｔｓ ０１의 지질다당류(ｌｐｓ) 특이적 인간 단일클론 항체
CA2525657A1 (en) Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa
US20240059764A1 (en) ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF
JP2011511625A5 (enExample)
IL277899B1 (en) Methods and compositions for treating yellow fever
JP2004506695A5 (enExample)